[
  {
    "ts": "2026-02-26T06:09:25+00:00",
    "headline": "IQVIA Acquisition Expands Drug Discovery Role And Highlights Valuation Gap",
    "summary": "IQVIA Holdings (NYSE:IQV) agreed to acquire discovery services assets from Charles River Laboratories. The deal focuses on in vitro discovery services and a small molecule AI platform that support non animal research methods. The transaction is intended to expand IQVIA's end to end drug discovery capabilities and broaden its therapeutic coverage. For investors watching NYSE:IQV, this move connects directly to IQVIA's role as a data driven partner for biopharma and healthcare clients. The...",
    "url": "https://finance.yahoo.com/news/iqvia-acquisition-expands-drug-discovery-060925501.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "39df6aab-0472-3f88-a0ce-d7491dc708b3",
      "content": {
        "id": "39df6aab-0472-3f88-a0ce-d7491dc708b3",
        "contentType": "STORY",
        "title": "IQVIA Acquisition Expands Drug Discovery Role And Highlights Valuation Gap",
        "description": "",
        "summary": "IQVIA Holdings (NYSE:IQV) agreed to acquire discovery services assets from Charles River Laboratories. The deal focuses on in vitro discovery services and a small molecule AI platform that support non animal research methods. The transaction is intended to expand IQVIA's end to end drug discovery capabilities and broaden its therapeutic coverage. For investors watching NYSE:IQV, this move connects directly to IQVIA's role as a data driven partner for biopharma and healthcare clients. The...",
        "pubDate": "2026-02-26T06:09:25Z",
        "displayTime": "2026-02-26T06:09:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/aa699fbfacb1e146d6b73dd53e729fbb",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6nKISX1GLRwu7E4Xp7LSxg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/aa699fbfacb1e146d6b73dd53e729fbb.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cvUO2OUb4QTTAI.SWmf2EA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/aa699fbfacb1e146d6b73dd53e729fbb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-acquisition-expands-drug-discovery-060925501.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-acquisition-expands-drug-discovery-060925501.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            },
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T11:42:59+00:00",
    "headline": "IQVIA to acquire Charles River drug discovery assets",
    "summary": "The expanded offerings will allow IQVIA to serve a broader range of drug modalities and therapeutic areas.",
    "url": "https://www.pharmaceutical-technology.com/news/iqvia-acquire-charles-river-assets/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "45769f46-958a-3561-b8f5-0e14f819f7dc",
      "content": {
        "id": "45769f46-958a-3561-b8f5-0e14f819f7dc",
        "contentType": "STORY",
        "title": "IQVIA to acquire Charles River drug discovery assets",
        "description": "",
        "summary": "The expanded offerings will allow IQVIA to serve a broader range of drug modalities and therapeutic areas.",
        "pubDate": "2026-02-26T11:42:59Z",
        "displayTime": "2026-02-26T11:42:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/01e5b85a04e2483f2b5394fff4ba4004",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "The integration benefits pharmaceutical and biotech sponsors. Credit: DW2630 / Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YP_PYsSH.uD3i.DAu9zBwg--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/01e5b85a04e2483f2b5394fff4ba4004.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nMU8XTEvkj.BMPYdm9gNsQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/01e5b85a04e2483f2b5394fff4ba4004.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/iqvia-acquire-charles-river-assets/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-acquire-charles-river-drug-114259160.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            },
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T14:03:33+00:00",
    "headline": "IQVIA Holdings (IQV) Rallied on Waning Concerns Over Biotech Funding and Clinical Activity",
    "summary": "Broyhill Asset Management, an investment advisor, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. 2025 witnessed extreme market concentration and a strong focus on artificial intelligence, leaving many sectors behind. The Portfolio, which has been significantly reshaped, now trades at a substantial discount relative to the broader market. […]",
    "url": "https://finance.yahoo.com/news/iqvia-holdings-iqv-rallied-waning-140333248.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9178117f-7c8d-3b18-9621-7f9256b2185b",
      "content": {
        "id": "9178117f-7c8d-3b18-9621-7f9256b2185b",
        "contentType": "STORY",
        "title": "IQVIA Holdings (IQV) Rallied on Waning Concerns Over Biotech Funding and Clinical Activity",
        "description": "",
        "summary": "Broyhill Asset Management, an investment advisor, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. 2025 witnessed extreme market concentration and a strong focus on artificial intelligence, leaving many sectors behind. The Portfolio, which has been significantly reshaped, now trades at a substantial discount relative to the broader market. […]",
        "pubDate": "2026-02-26T14:03:33Z",
        "displayTime": "2026-02-26T14:03:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/9798ba72df81dde053d4a2f1da22e6dc",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "IQVIA Holdings (IQV) Snaps 2-Day Losses on Higher-than-Expected Earnings",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/i27SR7sXwk45klUv2qLOEg--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/9798ba72df81dde053d4a2f1da22e6dc.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yRzPQayNySJAzkRIwfzk5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/9798ba72df81dde053d4a2f1da22e6dc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-holdings-iqv-rallied-waning-140333248.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-holdings-iqv-rallied-waning-140333248.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-26T13:48:55+00:00",
    "headline": "3 Reasons to Sell IQV and 1 Stock to Buy Instead",
    "summary": "Over the last six months, IQVIA’s shares have sunk to $163.04, producing a disappointing 13.2% loss - a stark contrast to the S&P 500’s 6.5% gain. This may have investors wondering how to approach the situation.",
    "url": "https://finance.yahoo.com/news/3-reasons-sell-iqv-1-134855174.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "8ec71f0a-8f26-3a57-b9b4-c691308c0f0d",
      "content": {
        "id": "8ec71f0a-8f26-3a57-b9b4-c691308c0f0d",
        "contentType": "STORY",
        "title": "3 Reasons to Sell IQV and 1 Stock to Buy Instead",
        "description": "",
        "summary": "Over the last six months, IQVIA’s shares have sunk to $163.04, producing a disappointing 13.2% loss - a stark contrast to the S&P 500’s 6.5% gain. This may have investors wondering how to approach the situation.",
        "pubDate": "2026-02-26T13:48:55Z",
        "displayTime": "2026-02-26T13:48:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/24070549d076ed63ce3e30be97c1f359",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "IQV Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T63.FuKezMn3IfaDQpt3fA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/24070549d076ed63ce3e30be97c1f359.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/05OLjRFBrGdNmOrY1wbEDA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/24070549d076ed63ce3e30be97c1f359.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-sell-iqv-1-134855174.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-sell-iqv-1-134855174.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IQV"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]